Print Page  |  Close Window

News Release

Printer Friendly Version View printer-friendly version
<< Back
HeartWare to Present at Canaccord Adams 29th Annual Global Growth Conference

FRAMINGHAM, Mass. and SYDNEY, Aug. 11 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR, ASX: HIN) today announced that it is scheduled to make an investor presentation at the Canaccord Adams 29th Annual Global Growth Conference at 2:00 pm EDT on Thursday, August 13, 2009. The conference will be held at the InterContinental Boston Hotel, August 11-13, 2009.

A live webcast of the Company's presentation at the conference will be available via a link provided at www.heartware.com. An archived replay of the presentation will be available shortly after the presentation time for a period of 90 days.

About HeartWare International, Inc.

HeartWare International, Inc. develops and manufactures miniaturized implantable heart pumps, or Left Ventricular Assist Devices (LVADs), to treat patients suffering from advanced heart failure. The HeartWare Ventricular Assist System features the HVAD(TM) pump, the only full-output pump designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices. HeartWare has completed an international clinical trial for the device involving five investigational centres in Europe and Australia. The device is currently the subject of a 150-patient clinical trial in the United States for a Bridge-to-Transplant indication.


For further information:
US Investor Relations
Matt Clawson
Partner
Allen & Caron Inc
Email: matt@allencaron.com
Tel: +1 949 474 4300

SOURCE HeartWare International, Inc.